ALTOR BIOSCIENCE CORPORATION

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
C07K PEPTIDES 19117
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 13242
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 9158
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 7199
 
  
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 594
 
  
 
B82Y SPECIFIC USES OR APPLICATIONS OF NANO-STRUCTURES; MEASUREMENT OR ANALYSIS OF NANO-STRUCTURES; MANUFACTURE  OR TREATMENT OF NANO-STRUCTURES152

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2017/0088,597 INTERLEUKIN-15 SUPERAGONIST SIGNIFICANTLY ENHANCES GRAFT-VERSUS-TUMOR ACTIVITYSep 23, 16Mar 30, 17[A61K, C07K]
2016/0199,523 SOLUBLE TCR MOLECULES AND METHODS OF USEFeb 10, 16Jul 14, 16[A61K, G01N]
2015/0216,937 METHODS FOR TREATING NEOPLASIAMar 15, 13Aug 06, 15[A61K]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9714279 HIV vpr-specific T-cell receptorsDec 04, 14Jul 25, 17[G01N, C07K]
9593152 Methods of treating disease with fusion molecules comprising IL-15 variantsDec 12, 14Mar 14, 17[A61K, C12P, C12N, G01N, C07K]
9464127 Fusion molecules and IL-15 variantsJul 19, 13Oct 11, 16[A61K, C12P, C12N, G01N, C07K]
9428573 Multimeric IL-15 soluble fusion molecules and methods of making and using sameJul 19, 13Aug 30, 16[A61K, C12P, C12N, C07K]
9328159 Multimeric IL-15 soluble fusion molecules and methods of using sameApr 01, 13May 03, 16[A61K, C07K]
9290560 Soluble TCR molecules and methods of useFeb 18, 14Mar 22, 16[A61K, B82Y, G01N, C07K]
9255141 Multimeric IL-15 soluble fusion molecules and methods of treating neoplasia and HIV using sameFeb 15, 13Feb 09, 16[A61K, C07K]
8940289 Fusion molecules and IL-15 variantsMar 23, 12Jan 27, 15[A61K, C12P, C12N, G01N, C07K]
8933198 HIV VPR-specific T cell receptorsMar 25, 10Jan 13, 15[G01N, C07K]
8772451 Soluble TCR molecules and methods of useNov 10, 04Jul 08, 14[C12Q, C07K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2013/0115,191 T CELL RECEPTOR FUSIONS AND CONJUGATES AND METHODS OF USE THEREOFAbandonedSep 12, 12May 09, 13[A61K, C07K]
2012/0230,995 POLYSPECIFIC BINDING MOLECULES AND USES THEREOFAbandonedDec 22, 11Sep 13, 12[A61K, A61P]
2011/0070,191 T CELL RECEPTOR FUSIONS AND CONJUGATES AND METHODS OF USE THERE OFAbandonedMar 19, 09Mar 24, 11[A61K, C07H, C12N, A61P, C07K]
7884198 Polynucleotides encoding humanized and chimeric antibodies specific for lipoteichoic acid of gram positive bacteriaExpiredDec 23, 08Feb 08, 11[C07H, A61K, C12P, C12N, C07K]
2010/0247,546 OPSONIC MONOCLONAL AND CHIMERIC ANTIBODIES SPECIFIC FOR LIPOTEICHOIC ACID OF GRAM POSITIVE BACTERIAAbandonedOct 02, 09Sep 30, 10[A61K, C07H, C12N, A61P, C07K]
7511122 Humanized and chimeric antibodies specific for lipoteichoic acid of GRAM positive bacteriaExpiredAug 01, 05Mar 31, 09[A61K, C07H, C12P, G01N, C07K]
2007/0292,490 Production of tissue factor in plantsAbandonedJun 22, 05Dec 20, 07[A61K, C12P, A61F, C12N, A01H, A61P, C07K]
2007/0116,718 Fusion proteins comprising bacteriophage coat protein and asingle-chain T cell receptorAbandonedJun 15, 06May 24, 07[A61K, C07H, C12P, C12N, C07K]
7141656 MHC complexes and uses thereofExpiredMay 03, 01Nov 28, 06[C07K]
2004/0253,632 Modulation of T -cell receptor interactionsAbandonedMay 16, 01Dec 16, 04[G01N]
2003/0144,474 T cell receptor fusions and conjugates and methods of use thereofAbandonedJun 05, 01Jul 31, 03[C07K]
2003/0093,818 Transgenic animals comprising a humanized immune systemAbandonedDec 19, 01May 15, 03[A01K]

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.